Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
75
currently held
Exits tracked
18
hand-checked
Sectors covered
1
across the portfolio
Countries covered
12
from every market
92 companies matching · Page 2 of 2
IM
Imperagen
Northern Gritstone Evergreen
Active
BiotechUK· Entry 2022Northern Gritstone
IN
Invizius
Old College Capital LP
Active
BiotechUK· Entry 2019Old College Capital
IB
Isavy Biotech
Generations powered by EDHEC
Active
BiotechFranceRing Capital
LA
LabGenius
Backed Fund I
Active
BiotechUK· Entry 2017BACKED VC
LS
LUCA Science
4BIO Ventures III
Active
BiotechJapan· Entry 20224Bio Partners
MA
Macomics
Old College Capital LP
Active
BiotechUK· Entry 2020Old College Capital
MB
March Biosciences
4BIO Ventures III
Active
BiotechUS· Entry 20244Bio Partners
ME
Mesenbio
DSW Ventures
Active
BiotechUK· Entry 2024DSW Venture Capital
MO
Molecule
Backed Fund II
Active
BiotechGermany· Entry 2021BACKED VC
MB
Montis Biosciences
ALSA Ventures European Biotechnology Fund
Active
BiotechBelgium· Entry 2020ALSA Ventures
MH
Multiomic Health
MMC Ventures EIS Fund
Active
BiotechUK· Entry 2023MMC Ventures
NE
NeoEarth
First Imagine! Ventures
Active
BiotechFrance· Entry 2025First Imagine! Ventures
NE
NeoVacs
Odyssee Venture Funds
Active
BiotechFranceOdyssée Venture
NB
Nido Biosciences
Abingworth Bioventures 8
Active
BiotechUS· Entry 2023Abingworth
NO
Novogaia
Backed Fund III
Active
BiotechUSA· Entry 2026BACKED VC
NT
Nuntius Therapeutics
Backed Fund II
Active
BiotechUK· Entry 2021BACKED VC
OB
Ochre-Bio
Backed Fund II
Active
BiotechUK· Entry 2020BACKED VC
PP
Pathalys Pharma
Abingworth Bioventures 8
Active
BiotechUS· Entry 2023Abingworth
PB
Pencil Biosciences
Northern Gritstone Evergreen
Active
BiotechUK· Entry 2023Northern Gritstone
PE
PepGen
Oxford Science Enterprises Balance Sheet
Active
BiotechUnited States· Entry 2018Oxford Science Enterprises
PT
Pheno Therapeutics
LifeArc Ventures
Active
BiotechUK· Entry 2020LifeArc
PR
Promatix
ALSA Ventures European Biotechnology Fund
Active
BiotechUK· Entry 2021ALSA Ventures
QB
Q32 Bio
Abingworth Bioventures VII
Active
BiotechUS· Entry 2020Abingworth
QT
Quell Therapeutics
Jeito I
Active
BiotechUnited Kingdom· Entry 2021Jeito Capital
RT
Resolution Therapeutics
Old College Capital LP
Active
BiotechUK· Entry 2020Old College Capital
RB
RQ Biotechnology
LifeArc Ventures
Active
BiotechUK· Entry 2022LifeArc
SB
Sable Bio
MMC Ventures EIS Fund
Active
BiotechUK· Entry 2025MMC Ventures
SG
Sano Genetics
MMC Ventures EIS Fund
Active
BiotechUK· Entry 2022MMC Ventures
ST
Scorpion Therapeutics
Abingworth Bioventures VII
Active
BiotechUS· Entry 2020Abingworth
SB
Sensible Bio
Backed Fund III
Active
BiotechUSA· Entry 2023BACKED VC
SB
Serna Bio
Backed Fund III
Active
BiotechUSA· Entry 2023BACKED VC
SB
Spruce Biosciences
Abingworth Bioventures VII
Active
BiotechUS· Entry 2020Abingworth
ST
StimOxyGen
DSW Ventures
Active
BiotechUK· Entry 2025DSW Venture Capital
TT
Tizona Therapeutics
Abingworth Bioventures VI
Active
BiotechUS· Entry 2016Abingworth
TR
Treefrog
Digital 3
Active
BiotechFrance· Entry 2019XAnge
TT
TRIMTECH Therapeutics
CIC Fund II
Active
BiotechUK· Entry 2025Cambridge Innovation Capital
TT
Trishula Therapeutics
Abingworth Bioventures VII
Active
BiotechUS· Entry 2020Abingworth
TR
Trogenix
IQ Capital Fund III
Active
BiotechUK· Entry 2023IQ Capital Partners
VA
Vaccitech
Oxford Science Enterprises Balance Sheet
Active
BiotechUK· Entry 2016Oxford Science Enterprises
VB
Vantage Biosciences
ALSA Ventures European Biotechnology Fund
Active
BiotechUK· Entry 2023ALSA Ventures
VT
Vera Therapeutics
Abingworth Bioventures 8
Active
BiotechUS· Entry 2021Abingworth
WU
Wugen
Abingworth Bioventures 8
Active
BiotechUS· Entry 2021Abingworth
Previous12Next